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Identifying the specific genetic characteristics of successfully transmitted variants may prove central to the
development of effective vaccine and microbicide interventions. Although human immunodeficiency virus
transmission is associated with a population bottleneck, the extent to which different factors influence the
diversity of transmitted viruses is unclear. We estimate here the number of transmitted variants in 69
heterosexual men and women with primary subtype C infections. From 1,505 env sequences obtained using a
single genome amplification approach we show that 78% of infections involved single variant transmission and
22% involved multiple variant transmissions (median of 3). We found evidence for mutations selected for
cytotoxic-T-lymphocyte or antibody escape and a high prevalence of recombination in individuals infected with
multiple variants representing another potential escape pathway in these individuals. In a combined analysis
of 171 subtype B and C transmission events, we found that infection with more than one variant does not follow
a Poisson distribution, indicating that transmission of individual virions cannot be seen as independent events,
each occurring with low probability. While most transmissions resulted from a single infectious unit, multiple
variant transmissions represent a significant fraction of transmission events, suggesting that there may be
important mechanistic differences between these groups that are not yet understood.
The development of a human immunodeficiency virus
(HIV) vaccine remains a global priority. Since vaccines need to
target viruses at, or close to, the time of infection, there is great
interest in understanding both the genetic characteristics of
viruses that are successfully transmitted and the genetic diver-
sification that ensues during the earliest stages of infection.
There is evidence from cross-sectional studies of individuals
with acute and early HIV infections that transmission is asso-
ciated with a population bottleneck (4, 9, 16, 35, 36, 39, 46–48).
The best evidence of transmission bottlenecks is obtained from
studies of HIV discordant couples, where infection is associ-
ated with transmission of one or a few genetic variants despite
high degrees of viral diversity in the transmitting donors (13).
A recent study was able to quantify this bottleneck by using
methodologies that could identify precisely the transmitted,
founder virus population (16). That study found that as many
as 76% of transmission events involved productive clinical in-
fection by only a single genetic variant in HIV-1 subtype B
transmission by either heterosexual or homosexual routes.
These findings are encouraging since in the majority of infec-
tions a vaccine-mediated response may have to protect against
only a low-multiplicity infection event that is associated with
low viral diversity in the initial days and weeks of infection.
However, it is also apparent that the transmission bottleneck
can be overcome, as evidenced by the transmission of multiple
viral variants (9, 10, 12, 16, 35, 36). The clinical implications of
multiple variant transmission are potentially serious because
coinfection with genetically divergent viral lineages has been
associated with more severe disease progression (10, 12, 37).
Current estimates of the frequency of multiple variant trans-
missions vary widely with between 0 and 50% of successful
sexual transmissions estimated to involve the transfer of mul-
tiple genetic variants (9, 16, 35).
It is still an open question as to whether there are distinctive
features of viruses that enhance their transmissibility and
whether different risk behaviors are associated with different
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numbers of transmitted viruses. For example, intravenous in-
fection has been associated with more heterogeneous infec-
tions than intravaginal infection in a rhesus macaque model
(11). Besides the potential identification of previously unrec-
ognized transmission risk factors, attempts to discover the vari-
ables influencing multivariant transmission event frequencies
should also provide insights into natural barriers to HIV in-
fection. Unfortunately, because of methodological variations
between studies it has not been possible to directly compare
results and to assess the impacts of biological factors such as
gender, routes of transmission, the presence of sexually trans-
mitted diseases and viral subtype on multiple variant transmis-
sion frequencies (39). Complex cofactors in a given risk cate-
gory may impact rates of transmission of multiple variants just
as they impact overall transmission rates (32).
In the present study, we investigated the genetic character-
istics of subtype C variants transmitted via a heterosexual route
in order to understand mechanisms involved in HIV transmis-
sion at genital sites. We used here the approach described by
Keele et al. (16), which allowed us to directly compare multiple
transmission frequencies between subtype B and C viruses.
Our results indicate that similar proportions of subtype B and
subtype C infections involve the transmission of multiple vari-
ants. Analysis of a total of 171 transmission events in both the
subtype B and C studies showed that infection with multiple
variants does not follow a Poisson distribution, suggesting that
transmissions of multiple variants are not independent events
in a setting of a low probability of infection. The question of
the biological basis of the mucosal viral transmission bottle-
neck and factors associated with its breach, however, remains
unanswered.
MATERIALS AND METHODS
Cohort description. Plasma was obtained from 69 individuals experiencing
early HIV-1 subtype C infection. Twenty-six were identified through prospective
monthly monitoring of HIV-negative women using rapid HIV tests and RNA
PCR (44) (CAPRISA 002 cohort, Durban, South Africa); 22 were identified (i)
with negative rapid HIV or enzyme immunoassay assay (EIA) antibody test
results but positive HIV RNA and/or p24 antigen test results or (ii) who were
antibody positive but antibody negative or Western blot indeterminate within the
previous 45 days (CHAVI 001 cohorts, South Africa and Kamazu Central Hos-
pital Sexually Transmitted Disease Clinic, Malawi). An additional 21 individuals
enrolled from the Sexually Transmitted Disease Clinic in Malawi were identified
as HIV PCR positive with a rapid HIV or EIA antibody-negative test or who had
indeterminate HIV Western blot results (30).
This study was approved by institutional review boards, and all participants
provided written informed consent.
Staging of HIV infection. The durations of HIV-1 infection were categorized
into six stages based on evolving HIV-1 RNA or antibody profiles developed by
Fiebig et al. (8). Plasma was tested for HIV RNA by using Roche Amplicor
vRNA assays (Rotkreuz, Switzerland) and for antibodies by EIA (BEP 2000
[Dade Behring, Marburg, Germany] or Determine AntiHIV-1/2 3rd Generation
EIA [Abbott, Illinois] and Uni-Gold Recombigen [Trinity Biotech, Ireland]) and
a GS HIV-1 Western blot analysis kit (Bio-Rad, Washington). Individuals clas-
sified as being in stage I were viral RNA positive and p24 antigen and EIA
antibody negative, those in stage II were RNA and p24 antigen positive but EIA
antibody negative, those in stage III were EIA antibody positive but Western blot
negative, those in stage IV had an indeterminate Western blot result, those in
stage V were Western blot positive but without reactivity to the p31 integrase
band, and those in stage VI were Western blot positive with a p31 band present.
PCR amplification and sequencing. HIV-1 RNA was extracted from 140 to
200 l of ACD or EDTA plasma and eluted in a 50-l final volume. The full
volume of RNA was reverse transcribed to cDNA (100-l reaction volume) by
using a Superscript III reverse transcriptase (RT) system (Invitrogen, California)
with an OFM-19 primer as described previously (16) or with oligo(dT). The
cDNA was then serially diluted to obtain no more than 30% positive amplifica-
tion reactions so that each amplicon would theoretically be amplified from a
single template more than 80% of the time (39). This limiting dilution approach
of env gene amplification was initially described by Simmonds et al. (41) and
Edmonson and Mullins (7) and was thereafter modified by Palmer et al. (29) by
sequencing of the amplicon directly and finally modified by Salazar-Gonzalez et
al. (39), who showed that single genome amplification of the env gene with direct
sequencing precludes recombination and Taq-induced error, and provides pro-
portional representation of each viral sequence. PCR products were directly
sequenced by using an ABI 3000 genetic analyzer (Applied Biosystems, Foster
City, CA) and BigDye terminator reagents. To ensure that sequences reflected
single templates from the viral populations in vivo, amplicons with sequence
chromatograms with “double peaks,” indicative of coamplification of more than
one template, were excluded. Sequences with deletions larger than 100 nucleo-
tides compared to the intraparticipant consensus were excluded.
Sequence analysis. Differences in sequences were visualized by using neigh-
bor-joining trees (MEGA 3.1) (43) and Highlighter nucleotide transition and
transversion plots (www.hiv.lanl.gov). Pairwise DNA distances were computed by
using MEGA 3.1.
Conformance of intraparticipant sequence diversity to a mathematical model
of random evolution was evaluated as described by Keele et al. (16) and Lee et
al. (H. Y. Lee, E. E. Giorgi, B. F. Keele, B. Gaschen, G. S. Athreya, J. F.
Salazar-Gonzalez, K. T. Pham, P. A. Geopfert, J. M. Kilby, M. S. Saag, E. L.
Delwart, M. P. Busch, B. H. Hahn, G. M. Shaw, B. T. Korber, T. Bhattacharya,
and A. S. Perelson, submitted for publication) whereby exponential viral repli-
cation from a single lineage is assumed to fix mutations at a constant rate, in the
absence of positive selection, using the following parameters: an HIV-1 gener-
ation time of 2 days (24), a reproductive ratio of 6 (i.e., assuming that the virus
replicates exponentially, for each currently infected cell six new cells will be
infected in the next generation) (42), and a replication error rate of 2.16  105
substitutions per site per replication cycle (23).
Time of divergence from the most recent common ancestor (MRCA) was
estimated by using BEAST (i.e., Bayesian Evolutionary Analysis Sampling Trees,
v1.4.7) (5, 6) with a relaxed (uncorrelated exponential) molecular clock and
general time-reversible substitution model, with relative substitution rate param-
eters estimated by using HyPhy (31), as described previously (16). We used a
gamma distribution with four categories and a proportion of invariant sites to
model rate heterogeneity across sites. Substitution rates were unlinked across
codon positions with a mean fixed at 2.16  105 substitutions per site per
generation (23).
Sequences were analyzed for evidence of APOBEC3G-induced hypermutation
by using the Hypermut 2.0 tool (www.hiv.lanl.gov). Sequences with a P value of
0.1 were considered enriched for mutations consistent with APOBEC3G sig-
natures. In sequence sets showing evidence of enrichment for APOBEC3G-
driven G-to-A transitions but with no single significantly hypermutated sequence,
hypermutation was tested for after superimposition of all mutations within that
sequence set onto a single representative sequence.
We used randomization to test whether there was evidence of clustering of
mutations within 10-amino-acid stretches putatively associated with cytotoxic-T-
lymphocyte (CTL) immune responses (14). Sites were classified as mutated in a
given patient if there was at least one sequence from the patient differing from
the patient consensus at that site. For each mutated site, we calculated its
nearest-neighbor distance as the distance between the site and the closest mu-
tated site to the left or right of it on the intrapatient sequence alignment. We
then compared the number of mutations with a nearest neighbor within 10 amino
acids to the number expected by chance by randomizing the locations of the
mutated sites 1,000 times. A P value was calculated as the fraction of randomized
datasets for which the proportion of mutated sites within 10 amino acids of
another mutated site was equal to or greater than the observed proportion. The
null hypothesis here is random distribution of mutated sites, which is consistent
with the model of neutral drift of the infecting virus in acute infection, proposed
by Keele et al. (16). Rejection of the null hypothesis suggests clustering of the
mutations on a scale consistent with escape from CTL responses.
Multivariant transmission was considered if (i) within-patient env diversity was
heterogeneous, with multimodal distribution of pairwise Hamming distances
(HDs; that is, the number of differing sites between sequences) and structure
within the phylogenetic trees, and (ii) if these deviations from the model of
random evolution from a single founder virus could not be accounted for by
APOBEC3G mutations, immune pressure, or stochastic events. For individuals
infected with more than one variant, our expectation was that when multiple
variants were transmitted, the sequences in the recipient should coalesce at a
time predating the estimated time of infection. The number of infecting variants
was enumerated, after accounting for recombination, by identification of distinct
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lineages on phylogenetic trees, together with examination of Highlighter transi-
tion and transversion plots (www.hiv.lanl.gov).
N-linked glycosylation sites were identified by using the N-glycosite program
(www.hiv.lanl.gov). HXB2 env protein amino acid locations for putative epitopes
were obtained by using the HIV sequence locator tool (www.hiv.lanl.gov). Motif
Scan (www.hiv.lanl.gov) was used to detect HLA anchor residue motifs within
putative epitopes and to search for matching potential epitopes.
Recombination analysis. The GARD (www.datamonkey.org/GARD/) (17,
18), RAP Beta version (www.hiv.lanl.gov), and RDP version 3.27 (http://darwin
.uvigo.es/rdp/rdp.html) (25) tools were used to detect recombination in intrapar-
ticipant sequence sets.
Modeling the probability of multivariant infection. We have assumed that
established infection with a single genotypic variant signifies that a single virus
particle was involved in the transmission event and that, in the setting of low
probability of transmission, this represents the minimal infectious dose. The
Poisson distribution was used to model the frequency of transmission of one, two,
or more variants under the assumption that the transmission of each variant
occurs with the same probability, i.e., as independent events. A left truncated
Poisson model was used (since the zero events, i.e., no transmission, are not
observed), and the model fitted to all of the data with a maximum-likelihood
method; this then allowed the frequency of zero events to be estimated given the
distribution of one, two, etc., variants being detected. A corresponding transmis-
sion probability was estimated as the sum of all probabilities for observing one or
more variants.
Statistical testing. Categorical variables were compared by using Fisher exact
tests (two-tailed). P values of 0.05 were considered significant.
GenBank accession numbers. The GenBank accession numbers for the 1,505
env sequences are FJ443128 to FJ444362.
RESULTS
Cohort description and timing of infection. Blood plasma
samples were obtained from 69 study participants (30 men and
39 women) from South Africa and Malawi who had recently
acquired HIV-1 infection through heterosexual contact (Table
1). A total of 42 of the participants were in the very early stages
of infection: 22 were in stage I/II (viral RNA positive, p24
antigen and EIA antibody negative, or RNA and p24 antigen
positive but EIA antibody negative), 6 were in stage III (EIA
antibody positive but negative by Western blotting), and 14
were in stage IV (EIA antibody positive with an indeterminate
Western blot result). Individuals in these stages had high viral
loads (mean of 6 million copies/ml) typical of acute infection
(Fig. 1). Twenty-seven participants were in the later stages of
primary infection, eighteen in stage V (Western blot positive
but without reactivity to the p31 integrase band) and eight in
stage VI (Western blot positive with a p31 band present), with
lower viral loads (medians of 84,572 and 21,176 copies/ml,
respectively); one individual was classified as being in stage V
or VI, with reactivity to p31 integrase not yet determined.
Characterization of env gene diversity. A total of 1,505 env
gene sequences encoding gp160 (with an average of 22 se-




A single variant More than one variant
Cohort
Total no. of subjects 54 15
No. of female subjects 32 7
No. of male subjects 22 8




Mean age in yr (female)  SD 29  10 25  7
Infecting virus
Maximum % DNA distance range 0.08–0.64 0.32–8.49
Median no. of infecting variants (range) 1 3 (2–5)
Viral load at 12 mo postinfectiona 39,300  106,072 (400–376,000) 70,100  532,413 (400–1,230,000)
CD4 counts at 12 mo postinfectionb 468  193 (303–1,030) 274  251 (188–695)
a Expressed as median copies/ml  the standard deviation (n  24).
b Expressed as median cells/l  the standard deviation (n  24).
FIG. 1. Log viral loads of 68 participants categorized into stage I/II
(viral RNA positive, p24 antigen and EIA antibody negative, or RNA
and p24 antigen positive but EIA antibody negative), stage III (EIA
antibody positive but negative by Western blot), stage IV (EIA anti-
body positive with an indeterminate Western blot result), stage V
(Western blot positive but without reactivity to the p31 integrase
band), and stage VI (Western blot positive with a p31 band present)
(8). Boxes represent the 70th percentile; horizontal bars represent the
median, and whisker bars correspond to minimum and maximum val-
ues. p24 antigen tests, which differentiate stages I and II of infection,
were not carried out for all participants; therefore, HIV RNA-positive,
enzyme-linked immunosorbent assay-negative individuals were classi-
fied as stage I/II. One participant was classified as being in stage V or
VI of infection and is thus not included in this figure. The mean
number of days postinfection was determined by Fiebig et al. (8) and
modified by Keele et al. (16).
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quences per participant; range, 15 to 42) were generated from
the 69 participants using single genome amplification and di-
rect sequencing of amplicons. All sequences were classified as
HIV-1 subtype C (Fig. 2). Fourteen participants clearly har-
bored highly heterogeneous viral populations (maximum in-
trapatient DNA distances of 0.73 to 8.49%) forming more than
one phylogenetic lineage. These individuals were postulated to
be infected with multiple variants and were further character-
ized to quantify the number of infecting variants. The remain-
ing 55 participants harbored virus populations with lower di-
versity (maximum intrapatient DNA distances ranging from
0.08 to 0.64%) with sequences clustering as single lineages with
no, or very little, structure within phylogenetic trees (see Ta-
bles S1A to S1C in the supplemental material). On further
analysis, one of the 55 individuals with a low diversity env
population, participant 1176, was subsequently found to be
infected with three closely related viruses.
All sequences were initially analyzed for evidence of
APOBEC3G-induced G-to-A hypermutation and, after re-
moval of these mutations from the relevant sequence sets, all
sequences were compared to a model of random evolution in
which infection with a single founder virus is followed by neu-
tral expansion characterized by exponential population growth
(16). This is expected to result in a star-like phylogeny and a
Poisson distribution for the intrapatient HD. Sequence sets
that did not conform to the model after the removal of the
G-to-A hypermutation were analyzed for evidence of immune
pressure, selection, or evidence of scattered APOBEC3G-re-
lated hypermutation, although not detected as significant (P 
0.1), to determine possible reasons for the deviation from the
model. Finally, the time of infection estimated from laboratory
staging was compared to the estimated time to the MRCA of
the sequences.
Two study participants were identified as being a donor-
recipient pair based on their sexual history and the close phy-
logenetic linkage of their viruses (Fig. 2). Participant
703010131 was assumed to be the donor since he was classified
as being in stage III infection, while the assumed recipient,
participant 703010159, was found to be in stage I/II.
Low env diversity after transmission. Of the 55 individuals
harboring viruses with low diversity, sequences from 30 indi-
viduals displayed Poisson distributed HDs and a star-like phy-
logeny consistent with infection with a single founder virus and
with the subsequent incorporation of randomly distributed mu-
tations (Fig. 3A and see Table S1A in the supplemental ma-
terial). Sequences from a further five individuals conformed to
the model following the removal of G-to-A substitutions em-
bedded in APOBEC3G signature patterns after showing sig-
FIG. 2. Neighbor-joining tree of env sequences from each of the 69
study participants from South Africa and Malawi. To limit the size of
the tree, only 626 sequences of the 1,505 sequences generated were
analyzed: where individuals harbored viruses with multiple identical
env sequences, only the unique sequences were included. Red
branches represent sequences from participants infected with more
than one variant. Diamonds represent sequences with 6% divergence
from the participant sequence population. The sequences for partici-
pants 703010131 and 703010159, a donor-recipient pair, cluster to-
gether, as indicated.
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nificant enrichment of these substitutions within a single se-
quence and/or within the overall participant sequence set with
no single overtly hypermutated sequence (P  0.1) (see Table
S1B in the supplemental material). In a sixth individual with
significant APOBEC3G-driven hypermutation (P  0.0067),
participant CAP85, sequences did not conform to a star-like
phylogeny even after removal of APOBEC-driven substitu-
tions (data not shown). This was not investigated further. Se-
quence sets for an additional two individuals (CAP225 and
704810053) conformed to the model following removal of scat-
tered G-to-A mutations, despite the fact that this hypermuta-
tion was not significant (P  0.1) (see Table S1B in the sup-
plemental material).
Thus, in seven of eight individuals, the model violation prior
to the removal of G-to-A substitutions would likely be due to
an increased relative mutation rate in these sites. This result is
similar to that reported for a small set of individuals identified
in the acute subtype B-infected cohort of Keele et al. (16),
where an overall enrichment of G-to-A substitutions in APO-
BEC motifs was scattered throughout the available sequences
in 7 of 81 homogeneous infections, with an additional six sub-
jects carrying one or more overtly hypermutated sequence. The
FIG. 3. env sequence diversity was visually determined by the structure of the phylogenetic tree (left), and the pattern of nucleotide base
mutations within sequences was observed on a Highlighter plot (right). The Highlighter plots compare sequences from each participant’s sequence
set to an intraparticipant consensus (uppermost sequence) and illustrate the positions of nucleotide base transitions and transversions using short,
color-coded bars. (A) Participant 1172 with a highly homogeneous env sequence population displaying limited structure on a tree and a few
nucleotide changes from the intraparticipant consensus. (B) Participant 1176 infected with three closely related env populations (indicated in black,
blue, and red, respectively) based on the clustering of sequences into individual clades on a tree and the shared patterns of mutations observed
on a Highlighter plot. Both participants were viral RNA positive but ELISA negative (stage I/II of infection).
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balance between HIV-1 Vif and APOBEC3G (22) may be
altered in such cases. In addition, a recent study suggests that
this type of pattern may be associated with improved clinical
outcome (19).
The remaining 17 of the 55 individuals with low-diversity env
populations had no evidence of enrichment for G-to-A hyper-
mutation but harbored virus populations that did not conform
to the model due to their having either non-Poisson-distrib-
uted HDs and/or non-star-like phylogenies. Six of these indi-
viduals were classified as infected with a single founder virus
based on divergence within a single lineage (n  2) and/or on
patterns of shared mutations between sequences (n  4) (i.e.,
internal branching in the intrapatient tree inconsistent with the
expected star-like phylogeny). These shared mutations were
possibly due to stochastic accumulation of neutral mutant al-
leles, either as neutral mutations that occurred very early in the
infection and could thus be established and retained in a high
enough frequency to be sampled or due to very early CTL
escape mutations.
A further 7 of these 17 individuals had evidence of early
antibody pressure with sequences showing loss or gain of N-
linked glycosylation sites or changes in envelope loop length;
all 7 were recruited in stages IV to VI of infection (Fig. 4). In
four of the seven participants, these changes occurred in the
V1/V2 loop region, which may indicate that this area is an early
target for immune pressure during primary infection.
Three of the seventeen individuals had evidence of cellular
immune pressure. In one individual there was a mutation as-
sociated with a known epitope (CAP8, HLA-B*0801). In the
other two individuals there was clustering of mutations within
10-mers (participants 70310054 and 705010015) (Fig. 4), a phe-
nomenon previously found to be associated with CTL escape
(14). The clustered mutations within these two participants’
10-mers fell within sequences found to contain HLA anchor
residue motifs for a range of HLA genotypes and which were
also matched to potential epitopes by Motif Scan (www.hiv.lanl
.gov). However, since the HLA types for these two individuals
are not known, the inference of putative CTL escape remains
speculative, and the relevance of these mutations unknown.
Finally, the last individual harboring low diversity virus, sub-
ject 1176, had sequences that exhibited shared mutations be-
tween sequence subsets and an estimated time to MRCA of 88
days, which exceeded the estimated time of infection since this
individual was in stage I/II infection; thus, we infer that this
subject was infected with three closely related viruses (average
DNA distance, 0.1%) (Fig. 3B).
In summary, of the 55 individuals with low diversity after
transmission, 54 were classified as likely to be infected with a
single variant, and 1 was classified as likely to be infected with
three closely related variants. For participants identified as
infected with a single infectious unit, the estimated time to the
MRCA was consistent with the expected time of infection with
one exception, participant CAP217, whose infecting virus dis-
played lower genetic diversity (mean, 0.02%) than expected,
given this participant was in Fiebig stage IV of infection (see
Table S1A in the supplemental material).
Infection with multiple unique infectious units. After cor-
recting for recombination and hypermutation, phylogenetic
analyses of the high diversity sequence sets indicated that all 14
were infected with more than one viral variant (see Table S1D
in the supplemental material). Including participant 1176 in-
fected with three closely related viruses brings the total num-
ber of individuals with multivariant infections to 15. Interlin-
eage recombination between transmitted variants was observed in
10 of the 14 individuals, using the Recombination Analysis
Program (www.hiv.lanl.gov) (Fig. 5). In 9 of these 10 cases,
recombination was also detected by GARD or RDP3.27 (18,
19, 26) or both. However, since donor samples were not avail-
able for these individuals, the transmission of recombinants
cannot conclusively be ruled out. In all 14 sequence sets, the
estimated number of days since the MRCA significantly ex-
ceeded the period for which the associated individual could
realistically have been infected (MRCA range, 605 to 5,998
days).
Therefore, including the individual infected with three
closely related variants, a total of 15 individuals were inferred
to be infected with multiple viruses. The median number of
readily distinguishable infectious units per individual was three
(range, two to five), with each viral lineage having a unique
pattern of nucleotide variation (Fig. 5). This represents the
minimum number of transmitted viruses in these individuals,
given the limitations in sampling. While we cannot exclude the
possibility that multiple variants were transmitted and a single
variant grew out at the time of detection, there is no bias for
the detection of multiple variants at earlier Fiebig stages
(Table 1).
Two of the fourteen participants, CAP37 and 1335, were
both infected with viruses with env sequences differing from
one another by more than 6% nucleotide sequence identity
(Fig. 2). Although the complete env sequences from these
individuals clustered as an outlier to the participant sequences,
the region encoding gp41 separated into distinct phylogenetic
branches separated by epidemiologically unlinked sequences.
This suggests that these two subjects had dual infections, al-
though it is not possible to determine whether these individuals
were infected by two independent transmission events from
different donors or if variants were cotransmitted from a donor
who had a dual infection.
Recombinant genomes result from the dual infection of
cells, followed by recombination in a subsequent round of
infection and thereafter outgrowth, allowing detection. We
sought to determine whether the detection of recombination
was related to the Fiebig stage. To have a large enough data
set, we pooled data from Fiebig stage I to III to compare them
to Fiebig stage IV to VI and also included the data reported by
Keele et al. (16). We detected the presence of recombinant
viruses at a significantly higher rate in the later Fiebig samples
(P  0.0015). In most individuals, we detected each recombi-
nant genome once. While we can conclude from these results
that the detection of recombinants becomes more likely with
later stages of infection, without corresponding donor samples
the possibility that detected recombinants were transmitted
cannot be ruled out. In particular, this could be the case with
participant CAP69 (stage I/II of infection) in whom we saw the
outgrowth of some recombinants (Fig. 5B).
Clustering of mutations. We screened all sequences for ev-
idence of the clustering of mutations. We identified tight clus-
ters of mutations by visual inspection, as well as by means of a
test based on randomizing the locations of mutated sites within
each patient in order to determine whether these mutations
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were significantly more clustered than would be expected by
chance. We focused specifically on clustering on a length scale
of 10 amino acids (roughly the size of a CTL epitope), since the
presence of clusters of mutations within a region of approxi-
mately this size is consistent with selective pressure resulting in
evasion of early cellular immune responses such as CTL re-
sponses (14). We determined the number of mutations with a
nearest neighbor within 10 amino acids and compared this to
the number expected by chance, estimated by randomizing the
locations of the mutated sites 1,000 times. Under a model of
neutral divergence (16), we expect mutated sites to be distrib-
uted randomly throughout the sequence. In addition, tight
clustering of mutations is unlikely even if purifying selection
were to affect a proportion of mutations. This would thus
suggest that mutations within these clusters would be favored
by selection.
Significant clustering was identified in 16 individuals (Fig. 4).
Nine of these individuals with clustered mutations had single
variant infections; six of these subjects (CAP129, CAP217,
0626, 703010193, 703010217, and 706010164) harbored se-
quences consistent with the model of neutral evolution from a
single founder virus (see Table S1A in the supplemental ma-
terial), suggesting that the virus populations from these indi-
viduals were under early selection despite the failure to reject
the model of neutral evolution. Clustered mutations were de-
tected in seven individuals with multivariant transmission.
As expected, most participants harboring sequences with
evidence of clustered mutations were in later stages of primary
infection (stages IV to VI) although, interestingly, three indi-
viduals with very early infection (stages I to III) harbored
sequences with clustered mutations, providing evidence for
very early selective pressure. In the absence of sequence data
from donor individuals, however, it is unknown whether any of
these mutations were transmitted.
Multiple variants are not transmitted as independent events
with low probability. Transmission of HIV-1 is infrequent (32),
and the homogeneity of sequences in acute infection suggests
that most transmission events represent the minimal infectious
dose. For both the subtype B (16) and the subtype C datasets
we found that ca. 80% of transmissions result in infection by a
single genotypic variant or a single virus particle. To determine
whether transmission of multiple variants represents indepen-
dent but concurrent infectious events where transmission of
the first variant had no effect on the probability of transmission
of the second (or third) variant, we modeled the number of
transmitted variants using the Poisson distribution and esti-
mated a putative transmission probability as the likelihood that
one or more variants are transmitted (equal to 1  the prob-
ability that no variants are transmitted). In Fig. 6 we show the
expected number of infections with one, two, or more than two
variants for when the probability of transmission in a single
exposure is 0.1, 0.25, and 0.4. Transmission probabilities in this
range are needed to observe the transmission of multiple vari-
ants at significant levels. In contrast, a more realistic transmis-
sion rate of 0.01, for example, would result in the transmission
of two variants once in 10,000 transmission events.
In Fig. 6 we also show the observed number of individuals
infected with one, two, or more than two variants in the sub-
type B and subtype C primary infection cohorts. When these
data are fitted to the Poisson model we estimate a transmission
rate of 0.48 for the subtype C data set (Poisson mean of 0.65
with a standard error of 0.12) and a transmission rate of 0.55
for the subtype B data set (Poisson mean of 0.80 with a stan-
dard error of 0.05). These rates of transmission are unreason-
ably high compared to reported sexual transmission rates,
which have a lower bound of 	0.001 (reviewed in Powers et al.
[32]). We therefore conclude that the transmission of multiple
variants does not represent low probability independent events
but rather results from either transiently high transmission
rates or linked transmission of multiple virions.
Multiple variant infection and disease progression. Of the
24 individuals monitored for 1 year postinfection, we found no
significant difference between viral RNA load set point or
CD4 T-cell counts in participants who were infected with a
single variant (19 of 24) compared to those infected with mul-
tiple variants (5 of 24) (P  0.3198 and P  0.2232, respec-
tively) (Table 1). However, 4 of 6 (67%) individuals with mul-
tiple variant infections had CD4 T-cell counts consistently
below 350 cells/l and were classified as rapid progressors,
whereas only 4 of 20 (20%) individuals that were infected with
single variants fell into this category. This association between
rapid disease progression and multiple variant transmission
(P  0.051) supports previous studies that have shown that
high diversity after infection is associated with increased rates
of disease progression (10, 12, 37).
DISCUSSION
This study is the first to provide a comprehensive assessment
of the multiplicity of HIV-1 subtype C infection in the context
of heterosexual transmission in men and women. Our findings
mirror observations of subtype B transmissions via heterosex-
ual or homosexual routes using the same methodology (16).
Together with the subtype B study, these data demonstrate
that in 171 individuals a single virus is responsible for infection
of 77% of individuals, with 23% of individuals infected with
FIG. 4. (A and B) Clustering of mutations within stretches of 10 amino acid residues associated with putative CTL pressure illustrated in
participant 703010054 (stage V of infection) (A) and participant 705010015 (stage V of infection) (B). (C and D) Changes in the V1/V2 loop in
env associated with putative antibody pressure illustrated in participant 704010017 (stage VI of infection) displaying clustered mutations within the
V2 loop resulting in the gain of three N-linked glycosylation sites (C) and participant CAP269 displaying multiple amino acid insertions within the
V1 loop resulting in the gain of one to four N-linked glycosylation sites (D). Highlighter plots (left) compare sequences from each participant’s
sequence set to an intraparticipant consensus (uppermost sequence) and illustrate the positions of nucleotide base transitions and transversions
using short, color-coded bars. Amino acid identity alignments (right) illustrate regions of clustering of mutations in sequences aligned with an
intraparticipant subtype C consensus sequence with corresponding HXB2 env protein locations indicated above. The number of sequences
harboring a particular mutation is displayed alongside each sequence. N-linked glycosylation sites are indicated as red amino acid residues. Where
significant mutational clustering was detected by a randomization test, P values are provided in parentheses.
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multiple variants. Based on the frequency of the transmission
of multiple variants, we find that infection with more than one
variant does not occur as independent events at low probabil-
ity. This implies that transmission of the second variant is
linked to transmission of the first variant. Understanding the
frequency and cause of multivariant transmission is relevant
since individuals infected with multiple variants would require
a vaccine that protects against greater initial viral diversity
instead of a single homogeneous virus population. In addition,
it is clinically important since high diversity following transmis-
sion has been associated with faster disease progression (10,
12, 37). In keeping with this observation, the present study
found an association between multivariant transmission and
disease progression.
Discrepant results due to differences in methodological ap-
proaches have hindered a clear understanding of multivariant
transmission. A key advantage of our study is that we used the
same methodological and analytical approaches to define the
founder virus population that was used recently to study sub-
type B acute infection (16), thus enabling us to clearly enu-
merate the infecting viruses and also directly compare results.
Despite different infecting subtypes and routes of transmission,
the frequencies of multivariant transmission were strikingly
similar: we report 22% in subtype C heterosexually infected
men and women compared to the 24% of participants infected
with subtype B via homosexual and heterosexual transmission
reported by Keele et al. (16). Phylogenetic analysis indicated
that the multiple variants came from a single donor in 87% of
the cases (13 of 15 subjects), and the time to the MRCA
demonstrates that the variants diverged at times significantly
before the transmission event.
This estimated frequency of multivariant transmissions
should, however, be considered a minimum. Many infections in
highly epidemic regions have been attributed to transmissions
during the acute stage of infection (30). Since this stage is
generally associated with a highly homogeneous viral popula-
tion, multiple variant transmissions in these instances could be
missed. In addition, we may miss variants present at a low
frequency (with a sample size of 20 sequenced amplicons, there
is 95% confidence of detecting sequences present at frequen-
cies greater than 15%) (16).
Although we used a model which assumes neutral evolution
(16), deleterious mutations will be lost through purifying se-
lection, and early innate and adaptive host responses are likely
to impact the apparent mutation rate, especially in participants
sampled after peak viremia. We did in fact identify putative
immune pressure in acute infection, with a third of the se-
quence sets containing evidence of putative CTL pressure
(based on clustered mutations) or antibody pressure (based on
changes in N-glycosylation sites or variable loop length). The
rates of mutation were also influenced by APOBEC3G-medi-
ated hypermutation observed in eight individuals with single
variant infections. In addition, sequences were under purifying
selection with a higher rate of synonymous (dS) compared to
nonsynonymous (dN) substitutions (mean dN/dS ratio of 0.79;
variance, 0.44). A mean dN/dS ratio of 1 suggests that the
rate of diversification of the sequences could be slightly less
than the rate estimated under a strict assumption of neutrality.
However, the impact of a relatively small departure from neu-
trality on the estimated times to the last common ancestors of
intrapatient sequence sets is likely to be minor.
The rate of HIV transmission is in the range of one trans-
mission event per 1,000 exposures (34; reviewed in Powers et
al. [32]), although two studies reported rates of 31 per 1,000
exposures (26), (40) and 97 per 1,000 exposures(3). However,
even rates as high as 0.03 to 0.1 cannot account for a frequency
of multivariant transmission of 22 to 24%, if multiple variants
are transmitted independently. This suggests that transmission
of each variant is not an independent event in the context of a
low transmission probability. One explanation of the frequency
of multiple variant transmissions is that different cofactors
transiently change the rate of multivariant transmission. The
distribution of frequency of one, two, and more than two vari-
ants can be explained if two rates are incorporated: one rate
would account for 70 to 75% of transmission events and have
a low probability of transmission with only rare occurrences of
the transmission of multiple variants; the second rate would
account for 25 to 30% of transmission events. However, a
probability of transmission of 	0.8 would be required to result
in equal numbers of transmission events of two variants and
more than two variants, which would approximate the ob-
served data. It is likely that increased transmission occurs as a
result of sexually transmitted infections (38) or traumatic
breaks in the epithelium. However, it is also possible that the
transmission of multiple variants represents a linked event, i.e.,
infection by one particle (or genome) is in some way linked to
an increased probability of infection with a second particle (or
genome). If the infectious unit were an infected CD4 T cell,
which can be infected with multiple viruses (15), this could
account for at least some of the multivariant transmission
events. A recent report has shown the potential for infected
cells to penetrate a disturbed epithelium (45), and the appar-
ent need for infection via infected cells in the case of HTLV-1
provides further support for a cell-mediated mechanism of
transmission (33). Alternatively, virus particles could be aggre-
gated by biological molecules such as SEVI (for semen-derived
enhancer of virus infection) (27) or tetherin during budding
(28), potentiating infection with two particles in a single, rare
transmission event.
A previous study from Kenya showed women were generally
FIG. 5. Highly heterogeneous, multiple variant env sequence populations are visually represented by phylogenetic trees with extensive branch
structure and discernible clades (left) and Highlighter plots with diverse patterns of nucleotide base mutations compared to the intraparticipant
consensus (right). env variants resulting from recombination between clades are displayed below with RAP (for recombination analysis program)
plots. Parental strains for each recombinant are color coded on the trees, with regions within each recombinant likewise color coded to correspond
to respective parental strains. Recombination breakpoints are illustrated by empty boxes on RAP plots. (A) Participant CAP37 was infected with
three distinct variants. Sequence 5998 differs by up to 6% from the remaining sequences from this participant and is a suspected dual infection.
(B) Participant CAP69 was infected with at least five distinct viruses with extensive recombination between clades. Six recombinant strains are
illustrated here.
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infected with more heterogeneous virus populations compared
to men (21). Although in our study, we did not find that
females were infected with higher-diversity viral populations
compared to men (data not shown), there were differences in
frequency of sexually transmitted infections, with genital ulcer-
ative disease being much more common in men from our study
than in women (82% versus 13%). Thus, since genital ulcer-
ative disease has an impact on transmission, this could con-
found our analysis. In addition, uncircumcised men are more
susceptible to infection (1, 2); thus, this difference in results
between studies may be due to the fact that most of the men in
our study were from Malawi where there is a very low fre-
quency of circumcision, whereas the Kenyan study recruited
from a cohort of individuals where 87% were circumcised (34).
In conclusion, infection with a single virus in the majority of
individuals demonstrates the severity of the genetic bottleneck
at transmission. These data in conjunction with the subtype B
analysis suggests a universal observation that mucosal HIV-1
infection most frequently originates from a single infectious
unit. Less frequently, multiple viral variants are transmitted,
which not only increases the genetic diversity, but this in-
creased diversity also provides the virus with greater opportu-
nity to escape early selective pressure through recombination.
Although the biological basis for the transmission of multiple
variants remains unknown, possible explanations include tran-
siently high rates of transmission due to cofactors, transmission
via a multiply infected cell, or transmission of viral aggregates.
Since one in five individuals will become infected with multiple
infectious variants, it is important to translate how this infor-
mation impacts on the breadth and targeting needed for pro-
tective vaccination.
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